• Medientyp: E-Artikel
  • Titel: The Need of Antimicrobial Stewardship in Post-Operative Infectious Complications of Abdominal Surgery
  • Beteiligte: Obst, Wilfried; Esser, Torben; Kaasch, Achim Jens; Geginat, Gernot; Meyer, Frank; Croner, Roland S.; Keitel, Verena
  • Erschienen: S. Karger AG, 2022
  • Erschienen in: Visceral Medicine, 38 (2022) 5, Seite 345-353
  • Sprache: Englisch
  • DOI: 10.1159/000526785
  • ISSN: 2297-4725; 2297-475X
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <b><i>Background:</i></b> Post-operative infection is a common complication following abdominal surgery. The two most common infections are secondary peritonitis and surgical site infections, which lead to increased perioperative morbidity, prolonged hospitalization, higher mortality rates, and increased treatment costs. In addition to surgical procedures, treatment is based on effective antibiotic therapy. Due to increasing antimicrobial resistance, the correct use of antimicrobials is becoming more complex. Many initiatives call for the implementation of an antimicrobial stewardship (AMS) programme to optimize anti-infective therapy. The review article summarizes current recommendations in anti-infective therapy of post-operative peritonitis and surgical site infections and highlights the importance of an AMS programme in abdominal surgery. <b><i>Summary:</i></b> Larger studies evaluating the benefit of AMS in abdominal surgery are lacking. However, national and international guidelines have formulated appropriate recommendations for the rational use of antibiotics in post-operative peritonitis and surgical site infections. The rate of post-operative infections can be significantly reduced by perioperative antibiotic prophylaxis. The increase in multidrug-resistant bacteria complicates anti-infective therapy for post-operative infections. Analysis of local susceptibility patterns helps choose an adequate empiric therapy. A high rate of extended-spectrum beta-lactamase-producing bacteria may necessitate the use of other reserve antibiotics in addition to carbapenems, which are approved for the treatment of complicated intra-abdominal infections. A key role for the AMS team is the subsequent de-escalation of antibiotic therapy which limits the use of unnecessary broad-spectrum antibiotics. <b><i>Key Messages:</i></b> The increase in multidrug-resistant bacteria poses challenges for abdominal surgery. Post-operative infections should be treated by an interdisciplinary team of surgeons and specialists for AMS.